Fundamental Analysis of Arcturus Therapeutics HLDG Inc. - Growth / Value Index
ARCT - Valuation Highlights
Valuation Analysis
Book Value in last 3 years is trending up
Tsr Value Index - Poor Score of 20.31
Valuation Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Price to Earning | -7.63 | 7.98 | -90.75 % | |
| Price to Book | 2.76 | 2.82 | -5.67 % | 3.03 |
| Price to Sales | 6.32 | 2.71 | -30.83 % | |
| Enterprise Value to EBITDA Multiple | -3.91 | 4.31 | -88.98 % |
ARCT - Profitability Highlights
Profitability Analysis
Piotroski F Score - Excellent Value of 8.0
Strong Return On Capital Employed of 35.66
Company Earning excess return
Annual Net Profit in last 3 years is trending up
EBITDA is continuously increasing for last 3 Years
Tsr Profitability Index - Very Poor Score of 5.00
Very Low Dividend Yield of 0 %
Negative Net Margin MRQ
Profitability Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Return On Equity | -36.16 | 35.27 | 919.70 % | -10.16 |
| Return On Asset | -23.59 | 23.13 | 1014.38 % | -6.40 |
| Net Profit Margin | -82.74 | 33.93 | 647.70 % | -70.55 |
| Operating Profit Margin | -95.51 | 21.02 | 255.54 % | -80.01 |
| EBITDA Margin | -92.38 | 35.38 | 498.88 % | -80.01 |
Highlights
| Market Cap | 802029 K |
| Enterprise Value | 455024 K |
| Price/Book TTM | 2.76 |
| Outstanding Share | 26931.80 K |
| Float/ Outstanding Share | 91.22% |
| Dividend Yield | 0 % |
Share Holding
Guru Numbers
| Price/Graham No | 0 |
| Peter Lynch Ratio | -128.52 |
| Piotroski F Score | 8.00 |
| Altman Z Score | 4.37 |
| Sloan Ratio | -0.101 |
| Peter Lynch Fair Value | 0 |
ARCT - Growth Highlights
Growth Analysis
Tsr Growth Index - Excellent Score of 83.02
STRONG JUMP IN NET SALE : YoY growth
Tremendous increasing trend in total sale last 3 year
YoY Net Margin Jump by 647.70%
Growth Key Fields
| Field | TTM | YoY Growth | QoQ Growth |
|---|---|---|---|
| Revenue | 125896 K | 42.10 % | 11.84 % |
| Gross Profit | 125896 K | 17.51 % | 11.84 % |
| EBITDA | -116299.00 K | 751.00 % | 100.90 % |
| Net Profit | -104162.00 K | 962.46 % | 212.81 % |
| EPS | -3.90 | 981.01 % | NA |
ARCT - Stability Highlights
Stability Analysis
Tsr Stability Index - Excellent Score of 90.62
Altman Z Score of 4.37 suggests good Stability
Paid More Than 50% of Debt, Heading towards debt free
Debt to equity ratio has decreased and is lowest in last five years
Cash ratio of 4.40
Stability Key Ratios
| Ratio | Latest FY | Yoy Change | MRQ |
|---|---|---|---|
| Debt to Equity Ratio | 0 | -100.00 % | 0.0162 |
| Cash Ratio | 4.40 | 42.59 % | |
| Quick Ratio | 4.90 | 0 % | 2.78 |
| Shareholders Equity | 65.59 | 9.29 % | |
| Debt to EBITDA | 0 | -100.00 % |
Historical Valuation Ratios of Arcturus Therapeutics HLDG Inc.
Historical Valuation Ratios
Loading ...
Historical Profitability Ratios of Arcturus Therapeutics HLDG Inc.
Historical Profitability Ratios
Loading ...
Historical Efficiency Ratios of Arcturus Therapeutics HLDG Inc.
Historical Efficiency Ratios
Loading ...
Historical Solvency Ratios of Arcturus Therapeutics HLDG Inc.
Historical Solvency Ratios
Loading ...
Note : All Data Generated at the End of Trading Hours (EOD Data)